| 今开：1.4 | 昨收：1.41 |
| 最高：1.44 | 最低：1.315 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.6398126E7 |
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-01 03:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006036 Act: 34 Size: 13 KB 网页链接查看全文
Cue Biopharma(CUE)04-27 04:05
$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072 Act: 34 Size: 1 MB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
$Cue Biopharma, Inc.(CUE)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-06-21 AccNo: 0001193125-18-199677 Size: 343 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-06-20 AccNo: 0001193125-18-197071 Size: 35 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-06-12 AccNo: 0001193125-18-190541 Size: 21 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Cue Biopharma, Inc.(CUE)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-05-29 AccNo: 0001193125-18-175561 Size: 81 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-05-29 AccNo: 0001193125-18-175557 Size: 84 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-05-17 AccNo: 0001193125-18-166591 Size: 8 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Cue Biopharma, Inc.(CUE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-14 AccNo: 0001564590-18-013461 Size: 2 MB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-04-30 AccNo: 0001193125-18-143781 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Cue Biopharma, Inc.(CUE)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-30 AccNo: 0001193125-18-143352 Size: 228 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-04-30 AccNo: 0001193125-18-143781 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接